Cargando…

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen

Colistin methanesulfonate (CMS) is an important treatment option for infections caused by carbapenem-resistant Gram-negative organisms (CROs). This study evaluated the pharmacokinetic/pharmacodynamic (PK/PD) profiles and safety of CMS in Chinese subjects following a recommended dosage. A total of 12...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Yaxin, Li, Yi, Chen, Yuancheng, Yu, Jicheng, Liu, Xiaofen, Li, Wanzhen, Guo, Beining, Li, Xin, Wang, Jingjing, Wu, Hailan, Wang, Yu, Hu, Jiali, Guo, Yan, Hu, Fupin, Xu, Xiaoyong, Cao, Guoying, Wu, Jufang, Zhang, Yingyuan, Zhang, Jing, Wu, Xiaojie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220111/ https://www.ncbi.nlm.nih.gov/pubmed/35740204 http://dx.doi.org/10.3390/antibiotics11060798

Ejemplares similares

Pharmacokinetics of Levornidazole Tablet in Healthy Chinese Subjects and Proposed Dosing Regimen Based on Pharmacokinetic/Pharmacodynamic Analysis
por: Wu, Hailan, et al.
Publicado: (2021)

Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
por: Chen, Yuancheng, et al.
Publicado: (2023)

Pharmacokinetics and Safety of Doripenem in Healthy Chinese Subjects and Monte Carlo Dosing Simulations
por: Wang, Yu, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against Streptococcus Pneumoniae
por: Li, Xin, et al.
Publicado: (2021)

Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
por: Li, Yi, et al.
Publicado: (2023)

Polymyxin B Combined with Minocycline: A Potentially Effective Combination against bla(OXA-23)-harboring CRAB in In Vitro PK/PD Model
por: Qu, Xingyi, et al.
Publicado: (2022)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
por: Yu, Zhenwei, et al.
Publicado: (2022)

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
por: Yang, Haijing, et al.
Publicado: (2022)

Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia
por: Zhou, Yingjie, et al.
Publicado: (2022)

The risk factors of colistin methanesulfonate associated nephrotoxicity
por: Tigen, Elif Tükenmez, et al.
Publicado: (2016)

Association between Augmented Renal Clearance and Inadequate Vancomycin Pharmacokinetic/Pharmacodynamic Targets in Chinese Adult Patients: A Prospective Observational Study
por: Zhao, Jinjin, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens
por: Bian, Xingchen, et al.
Publicado: (2022)

Proteomic Response Revealed Signaling Pathways Involving in the Mechanism of Polymyxin B-Induced Melanogenesis
por: Zhang, Chuhan, et al.
Publicado: (2022)

Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review
por: Zabidi, Mohd Shafie, et al.
Publicado: (2021)

Neurotoxicity associated with colistin methanesulfonate treatment is enhanced by concomitant sevoflurane inhalation
por: Gotoda, Mai, et al.
Publicado: (2022)

Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli
por: Hao, Min, et al.
Publicado: (2022)

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
por: Hu, Yingying, et al.
Publicado: (2023)

Case Report: Therapeutic Drug Monitoring of Polymyxin B During Continuous Renal Replacement Therapy in Two Pediatric Patients: Do Not Underestimate Extracorporeal Clearance
por: Xu, Caifang, et al.
Publicado: (2022)

Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery
por: Lu, Cheng, et al.
Publicado: (2016)

Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis
por: Wu, Junzhen, et al.
Publicado: (2023)

Intra-Pleural Colistin Methanesulfonate Therapy for Pleural Infection caused by Carbapenem-Resistant Acinetobacter Baumannii: A Successful Case Report
por: Rana, Muhammad Asim, et al.
Publicado: (2014)

Azithromycin possesses biofilm–inhibitory activity and potentiates non-bactericidal colistin methanesulfonate (CMS) and polymyxin B against Klebsiella pneumonia
por: Moshynets, Olena V., et al.
Publicado: (2022)

LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA(®) in Chinese healthy male subjects
por: Cao, Guoying, et al.
Publicado: (2023)

Diisopropylammonium methanesulfonate
por: Reiss, Guido J., et al.
Publicado: (2011)

A Randomized, Double‐Blind, Parallel‐Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the Originator Adalimumab in Chinese Healthy Male Subjects
por: Cao, Guoying, et al.
Publicado: (2020)

Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate
por: Schiaroli, Elisabetta, et al.
Publicado: (2015)

High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia
por: Omrani, Ali S, et al.
Publicado: (2015)

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review
por: Karaiskos, Ilias, et al.
Publicado: (2023)

2-Nitrobenzyl methanesulfonate
por: Anuradha, Venkatramu, et al.
Publicado: (2014)

Structure and vibrational spectroscopy of methanesulfonic acid
por: Zhong, Lisha, et al.
Publicado: (2018)

Electrochemically Initiated Synthesis of Methanesulfonic Acid
por: Britschgi, Joel, et al.
Publicado: (2022)

In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae
por: Yu, Wei, et al.
Publicado: (2017)

Brahmarasayana protects against Ethyl methanesulfonate or Methyl methanesulfonate induced chromosomal aberrations in mouse bone marrow cells
por: Guruprasad, Kanive Parashiva, et al.
Publicado: (2012)

Occurrence of False Positive Results for the Detection of Carbapenemases in Carbapenemase-Negative Escherichia coli and Klebsiella pneumoniae Isolates
por: Wang, Peng, et al.
Publicado: (2011)

3,5-Dinitrobenzyl methanesulfonate
por: Khan, Gul S., et al.
Publicado: (2008)

Hexaaquaaluminium(III) tris(methanesulfonate)
por: Trella, Thomas, et al.
Publicado: (2012)

Structure and vibrational spectroscopy of lithium and potassium methanesulfonates
por: Parker, Stewart F., et al.
Publicado: (2020)

Generating homozygous mutant populations of barley microspores by ethyl methanesulfonate treatment
por: Huang, Linli, et al.
Publicado: (2023)

Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients
por: Michalopoulos, Argyris S, et al.
Publicado: (2011)

Colistin pharmacokinetics/pharmacodynamics and acute kidney injury: A difficult but reasonable marriage
por: Honore, Patrick M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6a9ajq2qjilnn8olfnbevnuka1